Skip to main content
Premium Trial:

Request an Annual Quote

AnVil to Screen Lung-Tumor Genes for NCI

NEW YORK, Feb. 6 - AnVil will analyze lung tumors for the National Cancer Institute in an attempt to find gene markers for lung cancer diagnostics and treatments, the company said recently.
 
AnVil, a data management and visualization company based in Burlington, Mass., will use its technologies to explore NCI gene-expression data to help it determine which genes may be linked to lung tumors or normal lung tissue.

The Scan

Unwrapping Mummies' Faces

LiveScience reports that Parabon NanoLabs researchers have reconstructed how three Egyptian mummies may have looked.

Study on Hold

The Spectrum 10K study has been put on hold due to a backlash, leading the researchers to conduct consultations with the autism community, Nature News reports.

Others Out There Already

Reuters reports that Sanofi is no longer developing an mRNA-based vaccine for SARS-CoV-2.

PNAS Papers on GWAS False Discovery, PRAMEF2 Role in Tumorigenesis, RNA Virus Reverse Genetics

In PNAS this week: strategy to account for GWAS false-discovery rates, role of PRAMEF2 in cancer development, and more.